chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Itching on her scalp; After that until today she has skin itching, it is a 5-6; muscle pain on the right arm, pain in the left thigh, muscle pain,muscle pain in the calf on her left leg; too much pain in her breast area; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (too much pain in her breast area), PRURITUS (Itching on her scalp), PRURITUS (After that until today she has skin itching, it is a 5-6) and MYALGIA (muscle pain on the right arm, pain in the left thigh, muscle pain,muscle pain in the calf on her left leg) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A, 022C21A and 058H21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, the patient experienced BREAST PAIN (too much pain in her breast area). In December 2021, the patient experienced PRURITUS (Itching on her scalp), PRURITUS (After that until today she has skin itching, it is a 5-6) and MYALGIA (muscle pain on the right arm, pain in the left thigh, muscle pain,muscle pain in the calf on her left leg). In December 2021, BREAST PAIN (too much pain in her breast area), PRURITUS (Itching on her scalp) and MYALGIA (muscle pain on the right arm, pain in the left thigh, muscle pain,muscle pain in the calf on her left leg) had resolved. At the time of the report, PRURITUS (After that until today she has skin itching, it is a 5-6) had not resolved.            It was reported that patient experienced breast pain that  lasted  for a week. Muscle pain on the right arm  lasted  for 4 days. Then for 4 days patient  had pain in the left thigh, muscle pain and in the calf on the left leg Patient experienced  itching on her scalp, her head for 2 days.After that until today she had skin itching, itching hands, shoulder, back, everywhere.  No concomitant information provided by the reporter No treatment information provided by the reporter
Narrative: Patient is a 99 YO male who presented to facility on around 2/9/2021 with complaints of nausea, vomiting, diarrhea, and low blood pressure day after COVID-19 Pfizer vaccine was administered. Patient received COVID-19 vaccine on 2/8/21 from facility. Caregiver reported to primary care nurse on 3/26/21 that patient was admitted with mild heart attack and sepsis. Patient was discharged, however length of hospital stay and details of treatment unknown.
over the course of ~24 hours starting the morning after the second dose: 100 degree fever, chills, joint and muscle pain and aches, extreme weakness and dizziness preventing most movement. couldn't stay sitting or standing due to dizziness and was bedridden for most of the day. could still eat and drink normally and didn't have any issues keeping fluids down, but general movement was extremely difficult and painful. the worst cause of the dizziness seemed to be through sight and was manageable as long as my eyes were kept closed. symptoms were treated with ibuprofen and acetaminophen and mostly cleared up by the next morning with the exception of mild aches and dizziness.
Awakened at 0200 with severe nausea and abdominal discomfort. Got out of bed, went to bathroom and voided. Walked back to bedside and I became diaphoretic and had a syncopal spell. My husband was able to arouse me immediately. B/P ( while flat on floor) 84/66. I hydrated and diaphoresis resolved in about 30-40 minutes. B/p improved to 114/68. Abdominal discomfort continued for several hours. Headache continued 01/26/2021.
On 12/19/18 the patient stated that her arm has been sore since she received her flu shot on 11/16/18. "It is starting to feel better now" - per the patient. She wanted to let us know that her arm was sore since, and we thought it should be reported. We stated yes for item 20 since it is improving.
Shortly after the vaccine my tongue begin feeling really thick and furry.  Moments later my lips began tingling causing me to seek medical attention.  My body got really shaky and I got really anxious but after about 45 minutes my body returned back to its normal state.  Later that day and up into that Saturday I was very fatigued, nauseous and the body aches were severe.
TWO WEEKS AFTER INJECTION  I GOT AS RASH AT THE INJECTION SITE.  THE RASH WAS ITCHY.   TOOK BENADRYL  AND THE SITE FELT LESS ITCHY SHORTLY AFTER.  THE RASH IS LIGHTER BUT STILL THERE.
Patient with 1 Moderna and 1 Pfizer COVID vaccination and COVID infection back on 11/30/21 who admitted with COVID detected test and positive for cough and fever.  Provider discharge note below:  "Brief Summary of Hospital Stay:  Covid positive Urine cx positive for E coli Hospital Course:  This 83-year-old female with a past medical history of rheumatoid arthritis, lymphocytic colitis, hypertension, who comes in comes in with 1 week of flu-like symptoms with body aches, fatigue, rhinorrhea, dry cough, change in taste.  She has some chronic frequent urination.  In the emergency room  she had fever, tachycardia, tachypnea, suggestive of sepsis.  she tested positive for COVID, urinalysis was abnormal suggestive of urinary tract infection.  She was admitted, started on Rocephin empirically.  She was not hypoxic, chest x-ray without infiltrates, did not require treatment for COVID.  Her COVID infection is minimally symptomatic with dry cough only.  Blood cultures were negative, urine cultures grew E coli, sensitive to cephalosporins.  She feels stronger, she worked with therapy.  She was transitioned to Keflex orally for urinary tract infection.  She is being discharged in stable condition to home with home health care with nursing, PT and OT. She had been admitted for COVID in December 2021, post negative in the meantime.  She received 2 doses of COVID vaccine."
Pt reports constant chest and shoulder (rt back) immediately after injection (not reported to nurse although pt asked to wait 15 minutes after injections). Reports pain to both shoulders (constant) after leaving clinic. Blotchy appearance to posterior area of right upper arm with warmth and swelling. Chills for 2 days, stomach pain and diarrhea next day. Right arm red next day, continued to be swollen and warm (subsiding at time of report), but visible (02/19/18).
Symptoms began to appear around 1:00 am, 6/16/2021. Symptoms included labored breathing, pounding heartbeat, lightheadedness, headache, chills, injection site soreness, and feeling unwell. Side effects were eased with Tylenol. Symptoms gradually diminished over the course of approximately seven days.
Mother returned to clinic after receiving Hep A, noted hives on his face  and arm 40 minutes after leaving office.  Urticarial rash as noted on left cheek, right arm & a few on his legs.  Lungs CTA bilat.; no lip or tongue swelling or resp distress noted.  RR 32. 5 mls of benedryl and prednisone administered at office. Observed for an hour, rash did resolve., Allergist was informed and did confirm that it was a probable allergic reaction to vaccine. Allergist did recommend patient stay on treatment with prednisone and benadryl for 5 days.
My wife, who was not vaccinated, got sick the day after I got my shot.  Had a fever and terrible headache for about a day and a half and just felt unwell.  Four days after I got the vaccine, she got her period 2.5 weeks early.
Covid-19; Covid-19; This is a spontaneous report received from a contactable reporter (Physician).  A 47-year-old female patient (not pregnant) received BNT162b2 (Pfizer-BioNTech COVID-19), on 17Mar2021 as dose 1, single (Batch/Lot number: unknown), on 07Apr2021 as dose 2, single (Batch/Lot number: unknown) and on 22Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 46 years for covid-19 immunisation. The patient's relevant medical history included: "Anxiety" (unspecified if ongoing); "migraine" (unspecified if ongoing); "hypercholesterolemia" (unspecified if ongoing); "Shellfish allergy" (unspecified if ongoing). Concomitant medication(s) included: SERTRALINE oral, start date: 18Mar2020. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "recovered" and all described as "Covid-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results; (16May2022) negative, notes: Rebound Covid-19 infection 1 week later after testing negative on 16May. Therapeutic measures were taken as a result of vaccination failure, covid-19. Patient received Paxlovid to treat vaccination failure, covid-19. Treatment start date: 12May2022, Treatment stop date: 16May2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events with the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.
No adverse reaction; fridge temps were out of acceptable range which caused spoilage of vaccines. Need to revaccinate.
difficult to lift the arm because of soreness; had little soreness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (had little soreness in the arm) and MOBILITY DECREASED (difficult to lift the arm because of soreness) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 011L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (LEVOTHYROXIN), LOVASTATIN, HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL HCTZ), OMEPRAZOLE, MULTIVITAMIN [VITAMINS NOS] and IRON for an unknown indication.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (had little soreness in the arm). On 14-Feb-2021, the patient experienced MOBILITY DECREASED (difficult to lift the arm because of soreness). At the time of the report, PAIN IN EXTREMITY (had little soreness in the arm) and MOBILITY DECREASED (difficult to lift the arm because of soreness) outcome was unknown.         Action taken with mRNA-1273 in response to the event was not applicable.  For mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was reported.   This case was linked to MOD-2021-010258 (Patient Link).
Grandmother reports baby had temperature yesterday, gave oral tylenol.  Baby woke up this morning with rash.  Grandmother contacted public health office as baby does not have insurance currently.  RN observed rash to entire body, concentrated mostly on legs, left thigh with pustule to possible injection site.  Scant spots to head, moderate to trunk and arms.  Baby is itching but grandmother reports that is normal at times baby gets rash of unknown origin.  Instructed on keeping baby home and away from immunocompromised people, unvaccinated people or pregnant women.  Gave number to local income based clinic to follow up with if does not improve or worsens or tylenol does not control fever.   Grandmother verbalizes understanding.
Injection sight had muscle pain and then swelling began.  Itching and redness occurred the day after the shot, and continued to expand the next three days.  Swelling also spread.  Day three it became warm to the touch.  Ice, Tylenol, and Benadryl were used.  Had not cleared as of this report.
Numbness, tingling in Arms, hands, legs and feet.  Difficulty raising arms and moving arms.   Muscle weakness in arms, hands, legs and feet.  Tingling in the face and numbness in the face.  Talked to the pharmacy about this as there were no answers when I reached out to the doctor I was told to elevate my legs at night.  Symptoms lasted for around two plus months.   I have now been referred to a neurologist.
Patient received shot on 10-5-11. She had rash on neck 10-6. She developed hives 10-7. She continues to have hives 4 days later but no worse. She has been taking BENADRYL and using Calamine lotion.
Patient called and stated she experienced Redness of arm, Warmth post covid imminzation. She stated the same reaction occurred w/ last Moderna IMZ. Which she received at another location and it was her left arm previously ( right arm now). Onset of symptoms was approx. 24 hours. She received care at Urgent Care Clinic and was given antibiotics.
Bad body aches all over, cold, skin is very sensitive and warm, headache, tired. No fever.
Information has been received from a 64 year old female who on 10-JUN-2008 was vaccinated with a dose of ZOSTAVAX (Oka/Merck). On 11-JUN-2008 the patient experienced rapid heart beat (120) and missed heart beats. At the time of the report, it was unknown if the patient had recovered from the events. Additional information has been requested.
Between 3am-6am on Monday, January 4th, I experienced chills, fever, body and joint pains, nausea, and vomitted. Throughout Monday, I was weak and tired with a fever and body ache.
This spontaneous report was received from a pharmacist via a company representative, referring to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (dose, frequency, route, lot # and expiration date were not reported. There was no concomitant medication reported. Later, the patient was inadvertently administered a second dose of ZOSTAVAX on an unspecified date, since the patient did not remember receiving the initial dose. No adverse effect was reported. Additional information has been requested.
information has been received from a physician concerning a 69 year old white female patient with a pertinent medical history ( no details provided) who on Jul 19 2004 was vaccinated with pneumococcal 23v polysaccharide vaccine (lot 646322/0530N), in the deltoid. Subsequently, the patient developed a red, swollen arm at injection site. Ice and analgesic treatment was reported. The reporting physician requested a lot check. No product quality complaint. Follow up information reported that the patient developed a red, tender, hot upper arm, The patient recovered. The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory, the lot complies with the standards of the Center for Biologics Evaluation and Research and was released. It was also reported that two other patients had a similar reaction (WAES0407USA02326, WAES0407USA02327). Additional information is not expected.
Patient experienced nausea without vomiting several minutes after receiving first dose of COVID-19 Pfizer vaccination. VS remained wnl during observation period. No associated weakness, paresthesias, abdominal pain, vision changes, SOB, wheezing, swelling, or hives. Patient reports not having eaten today. Suspect secondary to vagal response.  Patient given Zofran ODT with improvement of symptoms. Tolerated Capri-Sun pouch. Patient cleared to discharge from clinic and provided SIQ for today.
SWELLING, REDNESS, TENDERNESS, HEAT WELL BEYOND INJECTION SITE, ITCHING.
Patient had first Pfizer dose for the COVID-19 virus on 1/01/2021. on 1/16/2021 patient was tested positive for COVID.  she continues with loss of taste or smell.
The next morning I woke up with pain in my arm, I was told by the nurse that it was normal. On Nov. 1, 2012 I was still in pain and not able to lift my arm so I was unable to work, I went to the ER and I was diagnosed with a pinched nerve and neck spasms. I go to see a neurologist on Nov, 20, 2012 to find out if I have any nerve damage due to the injection hitting my nerve. I also was forced to leave my job due to not being able to preform.
Pt reports fever of 103 deg F and chills beginning approximately 72 hours after the vaccinations were administered.
I was extremely tired the day after, and continued to be tired with gradual improvement over a few days.  But I have not recovered my previous level of energy, which was already very, very low because of longstanding chronic fatigue syndrome.  My persistent vertigo (since 1989) is also worse than it was, and continues so after 2 weeks from date of first shot.
An itchy rash developed below the injection site.  It is as large as an orange, red and warm to touch.
diarrhea; gas; cramps; dehydrated,; being tired; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), FLATULENCE (gas), MUSCLE SPASMS (cramps), DEHYDRATION (dehydrated,) and FATIGUE (being tired) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Rheumatoid arthritis (which is controlled). Concomitant products included LEVOTHYROXINE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced DIARRHOEA (diarrhea), FLATULENCE (gas), MUSCLE SPASMS (cramps), DEHYDRATION (dehydrated,), FATIGUE (being tired) and CHILLS (chills). At the time of the report, DIARRHOEA (diarrhea), FLATULENCE (gas), MUSCLE SPASMS (cramps), DEHYDRATION (dehydrated,), FATIGUE (being tired) and CHILLS (chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information includes took something for diarrhea and drinking water.
This spontaneous report was received from a nurse, referring to a 4 year old male patient. The patient's historical drugs, medical history, concomitant therapies and concurrent conditions were not reported. On 02-MAR-2018, the patient was vaccinated with GARDASIL 9 unknown route of administration, lot # N021572, expiration date 01-MAY-2020, for prophylaxis (strength, dose and frequency were not reported). No adverse effects reported.
This spontaneous report as received from a nurse refers to a 2 year old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 25-SEP-2017, the patient was vaccinated with improperly stored VAQTA (dosing details were not reported) (lot # N017094, expiry date: 31-AUG-2018) for prophylaxis (incorrect product storage). No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1709USA007011: US-009507513-1709USA007012: US-009507513-1709USA007013: US-009507513-1709USA007014: US-009507513-1709USA000054:
In was reported in a letter to the Editor that an approximately 68 years old patient in authors clinic, with a documented history of red meat allergy since November 2008 required emergency department treatment and epinephrine administration upon receipt of live attenuated herpes zoster vaccine (manufacturer unknown) containing the Oka VZV strain in September 2014. Within minutes of vaccine administration in a local pharmacy she had a sensation of mental clouding progressing to lightheadedness, wheezing, and throat tightness and she self-administered 50 mg diphenhydramine five minutes after symptom onset. She sought emergency care 30 minutes after vaccine receipt at which point she was documented to be dyspneic, flushed, with facial, oral and uvular angioedema and bilateral conjunctival injections with stable vital signs and blood pressure of 149/83, without documented wheezing on pulmonary examination. She was placed on oxygen and administered an additional 25 mg of diphenhydramine, 8mg of intramuscular dexamethasone, 20 mg of famotidine, nebulized albuterol and 0.3 mg of intramuscular epinephrine for her respiratory distress, angioedema, and cutaneous signs. Her symptoms resolved within 20-30 minutes and she was discharged uneventfully after 3 hours observation. One month after her episode of anaphylaxis following vaccination in 2014, she was tested for alpha-gal allergy, with galactose-alpha-1,3-galactose slgE = 32.5 kU/L, beef slgE =23.1 kU/L, lamb/mutton slgE = 12.2 kU/L, and pork slgE = 17.1 kU/L. To authors knowledge, this was the first report of vaccine induced anaphylaxis associated with alpha-gal allergy. Authors somewhat limited the claim of complete causality by the presence of low level IgE antibodies to porcine gelatin in authors patient. Nevertheless, the presence of antigen binding directly to alpha-gal IgE found in patient sera and depletion of alpha-gal slgE in overnight incubation with ZOSTAVAX would suggest that the increased gelatin content or some other shared element in the manufacturing process of the vaccine increases the likelihood of alpha-gal contamination. Upon internal review, anaphylaxis was considered serious as medically significant. Additional information has been requested.
MFCT expiration 9/30/22--administered on 10/9/22
pt stated that after she got the vax she started feeling really bad.  She can hardly mover her left arm.  Her arm is swollen and had a red mark around the injection.  She has fever, headache and is fatigued.  Next day she has all the same symptoms plus chills and has a funny taste in mouth.  She is alternately ibuprofen and Tylenol for her head ache and fever (temp 101.5) but neither has helped.  Pt states she will go to the ER if she doesnt feel better within the next 3 hours.
Hoarseness, wheezing, weakness, difficulty breathing. Sent employee to medical center for evaluation. TX with steroids.
pt recvd vax; erythema multiforme; diffuse pruritic rash on trunk & neck; bullous w/ desquamazation; 10jan94 referred to allergist;
About 5 minutes after receiving the Moderna COVID vaccine, patient stood up to ask the pharmacy for a cup of water. His eyes rolled back and he gently fell to the ground. Opened his eyes almost immediately after, had a strong pulse and no shortness of breath. Patient states it was just nerves. 911 and store management was called just incase. The paramedics check patient out and released him. Patient's mom came to pick him up.
Brachial Plexopathy in left arm. Deltoid and bicep muscles cease to function causing advancing atrophy destroying my life. Had nerve transfers performed. I can't lift my left arm. My right arm has severe weakness and severe atrophy. Though not the total devastation experienced in my right arm but a nightmare  nonetheless.